NEWS
SHL Medical | 2018.08

SHL to Shine at 2018 PDA Universe of Pre-Filled Syringes and Injection Devices

This October, SHL Group will participate in the Parenteral Drug Association's largest conference of this year, the Universe of Pre-Filled Syringes and Injection Devices.

SHL will proudly showcase a range of innovative technologies and state-of-the-art designs that deliver high-quality products with an intuitive, user-friendly experience. Among the top displays this year is SHL's unique Needle Isolation Technology (NIT®), a market-proven mechanism applied in auto injectors that carry cartridges with pre-installed needles to prevent contamination and enhance user safety. Another highlight will be the Rotaject®, a patented clock spring technology for the constant force delivery of high volume and high viscosity drug formulations of up to several hundred centipoise. Demonstrations on these high-tech and user-friendly devices will be held throughout the exhibition.

SHL's pioneering auto injector, Molly® will also be on display this year. Since its launch, Molly® has redefined the standards of production timelines with its preconfigured designs and stood the test of time with its ultra-compact design and inherent flexibility. Visitors are welcome to stop by our booth and learn how Molly® can solve the commercialization challenges presented by increased competition in the race to market. Representatives will also answer questions on the company's comprehensive capabilities and vertically integrated final assembly, labelling and packaging services that reduce timelines to clinic, to market and to the patients in need.

With the 2018 PDA exhibit's theme being "Transforming Pre-Filled Systems through Innovation," the company is set on showcasing its ability to innovate and adapt through its connective products. Understanding the importance of innovation as a drive for success, SHL offers a full range of connected drug delivery solutions for next-generation healthcare, supported by years of deep knowledge in the industry and active partnerships in connected therapeutics. Managing director of SHL Connect, Markus Bauss will also co-present a talk on smart packaging at the main event on October 8, titled "Using Smart Packaging to Enhance Supply Chain Quality of Drug Delivery Devices – How Smart Primary Packaging and Object Aware Machinery Can Lead to Better Quality Outcomes."

"We are in an era where smart technology and digitization is seamlessly woven into a person's life, which inevitably will also include their healthcare. Patients are seeking more customized services and pharma companies are intent on providing them. We are ready to offer our best solutions for pharma companies at the Orlando event this year," said Magnus Fastmarken, the global marketing director of SHL Group.

The two-day exhibition will be held between October 8-9 at the Loews Royal Pacific in Orlando, Florida. Visit SHL at Booth 419-420 to find out more about how its drug delivery devices and comprehensive solutions can help bring your innovative drug formulation to life.

關於瑞健集團

瑞健集團為領航全球先進藥物輸送系統產業的設計、研發、及製造龍頭。其事業據點涵蓋位於瑞典、美國及台灣的現代化設計中心以及設立於亞洲的先進製造廠房。 瑞健主要客戶為世界知名藥廠以及生技公司,提供如自動化注射器,筆型注射器以及吸入器等高科技產品。集團持續投資於研發製造為開發新型高科技藥物輸送系統以符合市場趨勢,其中包括使用步驟簡化、注射器精密化、拋棄式/複用式多重選擇、劑量彈性化以及藥劑濃稠度之配合等。

集團目前全球已有超過 3,700 名員工,主要分為以下事業群:

SHL Medical 主要為製藥和生技企業設計、研發、及製造高科技藥物傳輸系統,也提供終端組裝、醫材標籤及包裝相關服務

SHL Healthcare 從事居家及醫院護理器材之研發製造

SHL Technologies 提供醫療科技及工業設備之 OEM 製造與相關服務

如欲更深入了解瑞健集團,請至公司網站 www.shl.group.

瑞健媒體聯絡人

info@shl-group.com